JSAM
WST icon

J. Safra Asset Management’s West Pharmaceutical WST Stock Holding History

J. Safra Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Buy
+33
New +$10.1K ﹤0.01% 384
2025
Q2 		– Sell
-2
Closed -$448 – 401
2025
Q1 		$448 Buy
+2
New +$551 ﹤0.01% 342

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

J. Safra Asset Management's WST Position: Q2 2026 in Review

J. Safra Asset Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 33 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #384 among its holdings. This is a return to the name: J. Safra Asset Management previously reported a position in WST as recently as Q1 2025.

J. Safra Asset Management first reported a position in WST in Q1 2025 and has held it in 2 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • J. Safra Asset Management held 33 shares of West Pharmaceutical worth $11.8K as of Q2 2026.
  • West Pharmaceutical was a new J. Safra Asset Management position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #384 holding.
  • J. Safra Asset Management first reported a position in West Pharmaceutical in Q1 2025 and has held it in 2 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.